Factors that may increase risk include pre-existing digestive conditions, dietary choices high in sulphur-containing foods, rapid eating habits, and concurrent medications affecting gut motility
Quick Answer: GLP-1 receptor agonists produce modest cholesterol reductions (LDL-C by 2-10%, triglycerides by 10-20%) but should complement, not replace, statin therapy for lipid management
Does insurance cover weight loss medications
The increased energy expenditure from glucagon receptor activation means your total daily expenditure is higher than it was on tirzepatide at equivalent body weight
Glucagon receptor activation promotes thermogenesis, increases energy expenditure, and mobilizes fat stores from the liver
Type 2 diabetes is a progressive condition requiring ongoing management, though some patients may reduce therapy with sustained lifestyle modifications under medical supervision